Skip to main content

Table 2 Reasons for involving consumers in clinical trials, and whether the impact of consumer involvement was reported

From: A snapshot of consumer engagement in clinical trials in Australia: results of a national survey of clinical trial networks and research organisations

 

Clinical trial network (n = 25)

Active trial (n = 12)

Completed trial (n = 10)

Main reason for involving consumers in clinical trial*

–

  

 Funding requirement

 

4 (33%)

3 (30%)

 Specific matter/issue that consumer involvement could address

 

7 (58%)

4 (40%)

 Consumer involvement has been useful in previous studies

 

8 (67%)

5 (50%)

 Other

 

3 (25%)

1 (10%)

Reports on the impact of consumer involvement

   

 Yes

3 (18%)

  

 No

14 (82%)

  

 Missing

8

  
  1. *Note reasons are not mutually exclusive so may sum to more than 100%. Percentages are rounded to the nearest whole number. Missing data is excluded